Personal information

No personal information available

Activities

Employment (2)

Fudan University Shanghai Cancer Center: Shanghai, CN

Director (Department of Radiation Oncology)
Employment
Source: Self-asserted source
Xiao-Long Fu

Shanghai Chest Hospital, Shanghai Jiao Tong University: Shanghai, CN

2014 to present | Director (Department of Radiation Oncology)
Employment
Source: Self-asserted source
Xiao-Long Fu

Education and qualifications (1)

Fudan University: Shanghai, CN

MD, PhD
Education
Source: Self-asserted source
Xiao-Long Fu

Funding (4)

National Key Research and Development Program of China

Grant
Ministry of Science and Technology of PRC (Beijing, CN)
Part of GRANT_NUMBER:

2016YFC0905502

Source: Self-asserted source
Xiao-Long Fu

Shanghai Chest Hospital Project of Collaborative Innovation

Grant
Shanghai Chest Hospital (Shanghai, CN)
GRANT_NUMBER:

YJXT20190101

Source: Self-asserted source
Xiao-Long Fu

Shanghai Jiao Tong University Medical Engineering Cross Research Funds

Grant
Shanghai Jiao Tong University (Shanghai, CN)
GRANT_NUMBER:

YG2017ZD10

Source: Self-asserted source
Xiao-Long Fu

The Project of Multi-center Clinical Research, Shanghai Jiao Tong University School of Medicine

Grant
School of Medicine, Shanghai Jiao Tong University (Shanghai, CN)
GRANT_NUMBER:

DLY201619

Source: Self-asserted source
Xiao-Long Fu

Works (17)

Clinical efficacies of different neoadjuvant therapies for non-small cell lung cancer

Translational Oncology
2025-01 | Journal article
Contributors: Xin-chen Tan; Xin-yun Song; Meng-qi Jiang; Neng-yang Wang; Jun Liu; Wen Yu; Qin Zhang; Xu-wei Cai; Wen Feng; Xiao-long Fu
Source: check_circle
Crossref

Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection

Neoplasia
2024-04 | Journal article
Contributors: Meng-qi Jiang; Li-qiang Qian; Yu-jia Shen; Yuan-yuan Fu; Wen Feng; Zheng-ping Ding; Yu-chen Han; Xiao-long Fu
Source: check_circle
Crossref

Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors

Medical Oncology
2022-02 | Journal article
Contributors: Chang-Lu Wang; Lan-Ting Gao; Chang-Xing Lyu; Qin Zhang; Wan-Qin Zeng; Wen-Tao Fang; Lei Zhu; Xiao-Long Fu
Source: check_circle
Crossref

Radiosensitivity-Specific Proteomic and Signaling Pathway Network of Non-Small Cell Lung Cancer (NSCLC)

International Journal of Radiation Oncology*Biology*Physics
2022-02 | Journal article
Contributors: Xueru Zhu; Yiting Wang; Chang Jiang; Xiaoyang Li; Linying Sun; Guangzhong Wang; Xiaolong Fu
Source: check_circle
Crossref

Bevacizumab in Combination with Paclitaxel and Platinum for Previously Treated Advanced Thymic Epithelial Tumor

2021-09-02 | Preprint
Contributors: Chang-Lu Wang; Lan-Ting Gao; Chang-Xing Lyu; Qin Zhang; Wan-Qin Zeng; Wen-Tao Fang; Lei Zhu; Xiao-Long Fu
Source: check_circle
Crossref

Lung adenocarcinoma radiosensitivity depends on EGFR signaling pathway or other pathways? —— a research based on gene sequencing and data-independent acquisition (DIA) mass spectrometry

2021-02-08 | Other
Contributors: Chang Jiang; Yi-ting Wang; Xue-ru Zhu; Wen Feng; Wen Yu; Li Sun; Qian Sun; Hao Jiang; Xiao-long Fu
Source: check_circle
Crossref

Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunological score approach

Therapeutic Advances in Medical Oncology
2021-01 | Journal article
Contributors: Wen Feng; Yuan Li; Lei Shen; Qin Zhang; Xu-Wei Cai; Zheng-Fei Zhu; Meng-Hong Sun; Hai-Quan Chen; Xiao-Long Fu
Source: check_circle
Crossref

Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC)

Radiation Oncology
2020-12 | Journal article
Contributors: Xueru Zhu; Runping Hou; Xiaoyang Li; Chang Jiang; Wuyan Xia; Xiaolong Fu
Source: check_circle
Crossref

Analysis of Progression Patterns and Failure Sites of Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Receiving First-line Treatment of Tyrosine Kinase Inhibitors

Clinical Lung Cancer
2020-11 | Journal article
Contributors: Xiao-yang Li; Xue-ru Zhu; Chen-chen Zhang; Wen Yu; Bo Zhang; Tian-le Shen; Hong-yan Zhang; Xiao-long Fu
Source: check_circle
Crossref

Intensity-modulated Radiotherapy for Pleural Recurrence of Thymoma: A Prospective Phase II Study

International Journal of Radiation Oncology*Biology*Physics
2020-10 | Journal article
Contributors: Chang-Lu Wang; Lan-Ting Gao; Chang-Xing Lyu; Jia-Ming Wang; Jun Liu; Heng-Le Gu; Yuan Liu; Xiao-Long Fu
Source: check_circle
Crossref

Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study

Lung
2019-12-08 | Journal article
Contributors: Wan-Qin Zeng; Wen Feng; Li Xie; Chen-Chen Zhang; Wen Yu; Xu-Wei Cai; Xiao-Long Fu
Source: check_circle
Crossref

Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.

European radiology
2019-02-18 | Journal article
Source: Self-asserted source
Xiao-Long Fu

The pivotal role of DNA methylation in the radio‐sensitivity of tumor radiotherapy

Cancer Medicine
2018-08 | Journal article
Contributors: Xueru Zhu; Yiting Wang; Li Tan; Xiaolong Fu
Source: check_circle
Crossref

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma

Cancer Medicine
2018-06 | Journal article
Contributors: Xu‐Wei Cai; Wei‐Wei Yu; Wen Yu; Qin Zhang; Wen Feng; Mi‐Na Liu; Meng‐Hong Sun; Jia‐Qing Xiang; Ya‐Wei Zhang; Xiao‐Long Fu
Source: check_circle
Crossref

Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancer.

Radiotherapy and oncology
2015-01 | Journal article
Source: Self-asserted source
Xiao-Long Fu

Phase 2 study of accelerated hypofractionated thoracic radiation therapy and concurrent chemotherapy in patients with limited-stage small-cell lung cancer.

Int J Radiat Oncol Biol Phys
2014-12-03 | Journal article
Source: Self-asserted source
Xiao-Long Fu

Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design.

Int J Radiat Oncol Biol Phys
2014-02-11 | Journal article
Source: Self-asserted source
Xiao-Long Fu

Peer review (4 reviews for 3 publications/grants)

Review activity for Clinical epigenetics (1)
Review activity for Journal of cancer research and clinical oncology. (1)
Review activity for Radiation oncology. (2)